How Johnson & Johnson Made Hard Decisions During Covid

In early 2020, media reports indicated that an antiviral drug produced by Johnson & Johnson that was used to treat people with HIV might be effective against COVID-19. Orders for the medicine surged beyond what the pharmaceutical company could produce. Instead of ramping up production, though, the company paused and followed a specific playbook for responding to crisis.

About George Veth

George Veth is a consultant in the areas of strategy execution and initiative management. Most recently, he has been leading a cross-boundary collaboration program with teams from cities across North America and Europe. He lives in Cambridge, MA, and runs a nonprofit SME Impact Fund in East Africa. His subject matter interests are organizational culture, management [system] innovation, and public value management.